Coivas logo

Coivas Review

Best for: all-inclusive compounded GLP-1 pricing with a money-back guarantee

Coivas is an all-inclusive GLP-1 telehealth service operated by WellVi LLC (d/b/a Coivas) with prescriptions through Arora Health & Aesthetics, LLC. It offers compounded semaglutide from $149/mo and compounded tirzepatide from $229/mo on a quarterly plan (or $179/$289 monthly), with one price covering the doctor consult, prescription, shipping and support. Available in all 50 states, with a money-back guarantee.

By Eli Marsden · Founding Editor
Editorially reviewed (not clinically reviewed) · How we verify contentLast reviewed
7.8
★★★3.9
CompoundedSemaglutideTirzepatideAll-Inclusive PriceFree ShippingMoney-Back Guarantee
$149/mo

What the monthly price covers

Medication

Included

Provider visits

Included

Shipping

Included

Lab work

Not disclosed

Coaching

Not disclosed

See plans →

No insurance neededVetted by our editors

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

The Bottom Line

Coivas is a solid telehealth option with balanced features and pricing.

Score: 7.8/10Best for: all-inclusive compounded GLP-1 pricing with a money-back guaranteeFrom: $149/mo
Coivas logo
3.9 / 5
Our editorial rating
Visit Coivas

from $149/mo · no insurance needed

Coivas at a glance

Type
GLP-1 telehealth provider
Medications
Semaglutide, Tirzepatide
Starting price
$149/mo (Compounded Semaglutide Quarterly $149/mo (Monthly $179/mo) verified on coivas.com 2026-06-19; one price includes consult, Rx, shipping & support)
What's included
Medication · Consult · Shipping
FDA status
No FDA warning letter on record

How we scored Coivas

Each dimension is scored algorithmically from Coivas’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.

Value25%

8.3/10

At $149/mo, Coivas runs about 12% below the $170 median for GLP-1 providers.

Effectiveness25%

8.3/10

Coivas offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.

User Experience15%

7.6/10

Online intake and platform experience — consult included in the price; 6 platform features disclosed.

Trust & Safety15%

8.2/10

Core details confirmed by our editors; no FDA warning letters on file; dispenses through an accredited compounding pharmacy (last checked 2026-06-19).

Accessibility10%

6.3/10

Coivas's exact state footprint isn't published — confirm coverage in your state before signing up.

Support10%

6.1/10

Coivas provides standard clinician follow-up; no extended coaching or community program is disclosed.

How we verified this Coivas review

Last checked 2026-06-19
  • Confirmed current pricing across 2 dose/plan tiers
  • Confirmed what the monthly price does and doesn't include
  • Checked the FDA warning-letter database for enforcement actions
  • Walked the public intake/checkout flow on the provider's site

Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.

GLP-1 medications Coivas offers

Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.

Pricing

QuarterlyCompounded
$149/mo
semaglutide

Compounded Semaglutide Quarterly $149/mo (Monthly $179/mo) verified on coivas.com 2026-06-19; one price includes consult, Rx, shipping & support

QuarterlyCompounded
$229/mo
tirzepatide

Compounded Tirzepatide Quarterly $229/mo (Monthly $289/mo) verified on coivas.com 2026-06-19

Ready to get started?

Plans and promotions change often — check Coivas's current pricing and active discounts before you decide.

See Coivas pricing →

What we like

  • All-inclusive pricing: one price covers doctor consult, prescription, shipping and support
  • Compounded semaglutide from $149/mo and tirzepatide from $229/mo on the quarterly plan
  • Names its clinical provider (Arora Health & Aesthetics, LLC) and cites USP 797 / NABP-accredited pharmacies
  • Available in all 50 states; 24/7 support; HSA/FSA eligible; money-back guarantee
  • Most patients approved in under 2 hours; refund if no provider visit or prescription occurs

Watch-outs

  • Dispensing pharmacies described only by category (503A/503B, NABP-accredited) - not named individually
  • Lower quarterly headline price requires a 3-month commitment; monthly plan costs more ($179/$289)
  • Money-back guarantee has strict adherence/verification conditions and no partial/prorated refunds
  • No brand-name Wegovy/Zepbound/Mounjaro/Ozempic - compounded injectable only; binding NY arbitration

Is Coivas worth it? Our verdict

Coivas positions itself around one thing: all-inclusive compounded GLP-1 pricing with a money-back guarantee. It runs $149/month — toward the affordable end of the market.

How much Coivas actually costs

  • Compounded semaglutide — $149/month
  • Compounded tirzepatide — $229/month

That puts Coivas below the roughly $170 median ongoing price across the GLP-1 providers we track — a real cost advantage.

Medications: what Coivas prescribes

Coivas prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro) — the two molecules with the strongest published weight-loss trial outcomes. These are dispensed as compounded formulations from a licensed pharmacy, which is how the price stays below brand-name pens. Compounded drugs aren't FDA-approved as finished products — the standard trade-off across the compounded-GLP-1 market.

Who Coivas is best for — and who should skip it

A good fit if you…

  • are focused on the lowest ongoing monthly cost.

Look elsewhere if you…

  • specifically want an FDA-approved brand-name pen.
  • need to bill insurance — like most of this market, it's cash-pay.

Trust, safety, and medical oversight

Coivas dispenses through an accredited compounding pharmacy. We found no FDA warning letters on file for the provider. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation — we explain how in our scoring methodology.

Bottom line

Coivas earns its place on the shortlist mainly on price: at $149/month it's one of the more affordable ways to stay on a GLP-1, without obvious corners cut on access or oversight.

Ready to start with Coivas?

Starting at $149/month. See current pricing and start your free consultation.

Alternatives to Coivas

9.0/ 10
Verified partner

TrimRx

Best for: best overall value

★★★★4.5

Editorial score · methodology

$199/mo
CompoundedSemaglutide
Get StartedRead full TrimRx review →
8.6/ 10
Verified partner

Enhance MD

Best for: lab-monitored compounded GLP-1 with mandatory video visit

★★★★4.3

Editorial score · methodology

$49/mo
CompoundedSemaglutideTirzepatide
Get StartedRead full Enhance MD review →
8.6/ 10
Verified partner

Novi

Best for: transparent all-in compounded GLP-1 pricing

★★★★4.3

Editorial score · methodology

$174/mo
CompoundedSemaglutideTirzepatide
Get StartedRead full Novi review →

Frequently Asked Questions

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

Sources

The primary regulatory filings and peer-reviewed studies cited throughout this Coivas review:

Sources & methodology — as of June 2026
  1. 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)WeightLossRankings.org.
  2. 2.FDA — Compounding and the 503A Pharmacy FrameworkU.S. Food & Drug Administration.
  3. 3.FDA — Drug Shortages Database (current shortage listings)U.S. Food & Drug Administration.
  4. 4.PCAB — Pharmacy Compounding Accreditation Board StandardsAccreditation Commission for Health Care (ACHC) / PCAB.
  5. 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)Kaiser Family Foundation.
  6. 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)New England Journal of Medicine.PMID: 33567185.
  7. 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDAU.S. Food & Drug Administration.
  8. 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDAU.S. Food & Drug Administration.
  9. 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)New England Journal of Medicine.PMID: 35658024.
  10. 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDAU.S. Food & Drug Administration.
  11. 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDAU.S. Food & Drug Administration.
  12. 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)New England Journal of Medicine.PMID: 40334173.

Ready to start with Coivas?

Starting at $149/month. See current pricing and start your free consultation.